Global Albendazole Anthelmintic Drug Market Size, Share and Trends Analysis Report, By Type (Tablet and Capsule), By Application (Human and Veterinary), Forecast Period (2022-2028)

The global albendazole anthelmintic drug market is anticipated to grow at a CAGR of 6.8% during the forecast period (2022-2028). As the number of cases of neurocysticercosis climbs in the next years, so will the demand for albendazole treatments (infection caused by the pork tapeworm in the muscles, brain, and eyes that may cause seizures, brain swelling, and vision problems).

The dangerously high prevalence of human parasitic worm infections has spurred anthelmintic medication companies to boost their R&D capabilities for novel therapeutic options. For instance, in December 2019 Bayer Animal Health, a multinational provider of innovative animal health solutions said that it is expanding its research efforts to include prospective anthelmintic medications for the EU-sponsored Project Aid (Helminth Removal Platform) for human care. Soil-borne helminth infections are caused by different parasitic worm types. As of March 2020, about 1.5 billion people globally had been infected with soil-borne helminths, according to the WHO. This amount represents 24% of the global human population. Roundworms, trichuriasis trichiura (whipworms), necator americanus, and ancylostoma duodenale are some of the most common disease-causing species (hookworms). According to WHO data, the distribution of soil-transmitted helminth infection was higher in Sub-Saharan Africa, the Americas, China, and Asian countries in March 2020.

Helmonthasis, also known as worm infection, is a macroparasite disease characterized by parasitic worms (helminths) that infest the majority of the body (helminths). An increase in the prevalence of roundworm, hookworm, whipworm, and other worms is predicted to fuel the market for anthelmintic treatment. In exchange, the global economy’s size is expected to grow. According to the CDC, 2800 Angiostrongylus cantonensis infections were reported in thirty countries in 2018. The Government of India’s Ministry of Health and Family Welfare, for example, is putting forth a major effort to rid the country of worms on National Deworming Day. According to the WHO, 241 million children aged 1 to 14 years in India are at risk of parasitic intestinal worms. The government is also anticipated to issue suggestions for helminth infection prevention and eradication.

Some major players in the market include GlaxoSmithKline plc, Huazhong Pharmaceutical Co., Ltd, K.A.Malle Pharmaceuticals, SeQuent, among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, GlaxoSmithKline plc offers Zentel Chewable Tablet, It’s an antiparasitic drug that’s used to treat parasitic worm infestations. It works by eradicating the worms that cause infections and preventing the spread of infection.

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
  • By Type
  • By Application
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

Competitive Landscape- GlaxoSmithKline plc, Huazhong Pharmaceutical Co., Ltd, K.A.Malle Pharmaceuticals, SeQuent, among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
  • Deviation from the pre-COVID-19 forecast
  • Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Albendazole Anthelmintic Drug Market Report by Segment

By Type

• Tablet
• Capsule

By Indication

• Human
• Veterinary

Global Albendazole Anthelmintic Drug Market Report by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa